Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLORIA: Glufast or Basen with Insulin Glargine in Type 2 Diabetes
NCT00663884Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Feb 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by JW Pharmaceutical Corporation. Started Feb 2008; status: completed.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00663884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663884.